BNP Paribas Q3 Revenues Rise 4.7%

BNP Paribas (BNPQY.PK,BNP.L), on Friday, reported third-quarter revenues of EUR 11.4 billion, up 4.7% compared to EUR 10.9 billion generated a year ago, driven by very good performances at Domestic Markets and Wealth & Asset Management and strong revenues at CIB, including growth in all three of its businesses - Corporate Banking, Global Markets and Securities Services.

Net income, group share amounted to EUR 2.50 billion for the quarter, an increase of 32.2% versus the previous year's EUR 1.89 billion. Excluding the effect of exceptional items, net income was up by 33.8% to EUR 2.6 billion.

As at 30 September 2021, the common equity Tier 1 ratio stood at 13.0%1, up by 10 basis points compared to 30 June 2021. The Group's immediately available liquidity reserve amounted to EUR 478 billion, equivalent to more than one year of room to manoeuvre in terms of wholesale funding. The leverage ratio came to 3.9%.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Covid vaccine makers Pfizer Inc. and BioNTech SE announced a new $3.2 billion vaccine supply deal with the U.S. Government, as the country is bracing for a Covid outbreak this fall. Under the deal, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg) of Pfizer -BioNTech covid vaccines initially. The order may include adult Omicron-adapted COVID-19 vaccines. Samsung Electronics Co. has started the initial mass production of 3-nanometer or nm chips, which is considered as the most advanced chip in the world. In its move, the South Korean tech major beats rival Taiwan Semiconductor Manufacturing Co., the world's largest chip manufacturer, which is reportedly in the process to build one. Bryant Ranch Prepack Inc. is recalling certain Morphine Sulfate Extended-Release Tablets citing incorrect labeling, the U.S. Food and Drug Administration said. The recall involves one lot of Morphine Sulfate 30 mg Extended-Release tablets, and one lot of Morphine Sulfate 60 mg Extended-Release tablets to the consumer level.
Follow RTT